| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82a308524dd92f08d281d392c66fe6f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2835
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-143333 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56916
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2013-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521e97711df1593ba1de9cc1659b51b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53bef4428a4395bd2703a68e091e073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb18c637afaf0befde0e358b70914769
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_026be32c77a3973256c1a0ff1fcc217f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cd457623421bce8e1ca1153ba4d4ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97f8c05bce43f9497fad652fb6480b09 |
| publicationDate |
2014-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014147856-A1 |
| titleOfInvention |
Intestinal Permeability Assay for Neurodegenerative Diseases |
| abstract |
A method of identifying a subject at risk of developing or having a neurodegenerative disorder is provided. The method includes obtaining a biological sample from the subject and assaying a level of a marker of intestinal permeability in the sample. The method further includes comparing the subject's level to a control level for the marker of intestinal integrity and identifying the subject having an increased intestinal permeability relative to the control intestinal permeability as having an increased risk of developing or having a neurodegenerative disorder. A method of monitoring the efficacy of a treatment for a neurodegenerative disorder is also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019147990-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3626829-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10488418-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116205-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016036887-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568317-B2 |
| priorityDate |
2012-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |